A practical and scaleable total synthesis of the jaborandi alkaloid (+)-pilocarpine

Tetrahedron

Volumn 65, Issue 39, 2009, Pages 8283-8296

  Davies, Stephen G ^a   Roberts, Paul M ^a   Stephenson, Peter T ^a   Storr, Helen R ^a   Thomson, James E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Isopilocarpine; Jaborandi alkaloids; Pilocarpine; Pilosinine

Indexed keywords

ALKALOID DERIVATIVE; ISOPILOCARPINE; LACTONE DERIVATIVE; PILOCARPINE;

ARTICLE; CARBONYLATION; CHEMICAL ANALYSIS; CHEMICAL REACTION; CRYSTALLIZATION; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOCHEMISTRY;

PILOCARPUS JABORANDI;

EID: 69049102011     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2009.07.010     Document Type: Article

References (85)

1. Hardy E. Bull. Soc. Chim. Fr. 24 (1875) 497
2. Gerrard A.W. Pharm. J. 5 (1875) 86
3. Jowett H.A.D. J. Chem. Soc., Chem. Commun. 77 (1900) 473
4. Jowett H.A.D. J. Chem. Soc., Chem. Commun. 78 (1900) 851
5. Pinner A., and Kohlhammer E. Ber. Dtsch. Chem. Ges. 33 (1900) 2357
6. Pinner A., and Kohlhammer E. Ber. Dtsch. Chem. Ges. 33 (1900) 1424
7. Jowett H.A.D. J. Chem. Soc., Chem. Commun. 79 (1901) 580
8. Jowett H.A.D. J. Chem. Soc., Chem. Commun. 79 (1901) 1331
9. Pinner A., and Kohlhammer E. Ber. Dtsch. Chem. Ges. 34 (1901) 727
10. Pinner A., and Schwarz R. Ber. Dtsch. Chem. Ges. 35 (1902) 192
11. Pinner A., and Schwarz R. Ber. Dtsch. Chem. Ges. 35 (1902) 2441
12. The absolute (3S,4R)-configuration of (+)-pilocarpine 1 was established in 1966, see:. Hill R.K., and Barcza S. Tetrahedron 22 (1966) 2889
13. Battersby A.R., and Openshaw H.T. In: Manske R.H.F., and Holmes H.L. (Eds). The Alkaloids Vol. 3 (1953), Academic, New York, NY 201
14. Maat L., and Beyerman H.C. In: Brossi A. (Ed). The Alkaloids Vol. 22 (1983), Academic, New York, NY 281
15. Dreisbach R.H. J. Pharmacol. Exp. Ther. 131 (1961) 257
16. Levy B., and Ahliquist R.P. J. Pharmacol. Exp. Ther. 137 (1962) 219
17. Dreisbach R.H. Am. J. Physiol. 204 (1963) 497
18. Watson P.G. Br. J. Ophthalmol. 56 (1972) 145
19. Schwartz B. N. Engl. J. Med. 290 (1978) 182
20. Talyor P. In: Gilman A.G., Goodman L.S., and Gilman A. (Eds). The Pharmacological Basis of Therapeutics. 6th ed. (1980), Macmillan, New York, NY 96
21. Leopold I.H., and Keates E. Clin. Pharmacol. Ther. 6 (1968) 262
22. Worthen D.M., Zimmerman T.J., and Wind C.A. Invest. Ophthalmol. 13 (1974) 296
23. Sanders H.J. Chem. Eng. News 63 (1985) 30
24. Aboul-Enein H.Y., and Al-Badr A.A. Methods Find. Exp. Clin. Pharmacol. 4 (1982) 321
25. Preobrashenski N.A., Poljakowa A.M., and Preobrashenski W.A. Ber. Dtsch. Chem. Ges. 69 (1936) 1835
26. Dey A.N. J. Chem. Soc., Chem. Commun. (1937) 1057
27. Chumachenko A.V., Zvonkova E.N., and Evstigneeva R.P. J. Org. Chem. U.S.S.R. (Engl. Trans.) 8 (1972) 1112
28. DeGraw J.I. Tetrahedron 28 (1972) 967
29. Link H., and Bernauer K. Helv. Chim. Acta 55 (1972) 1053
30. Noordam A., Maat L., and Beyerman H.C. Rec. J. R. Neth. Chem. Soc. 100 (1981) 441
31. Compagnone R.S., and Rapoport H. J. Org. Chem. 51 (1986) 1713
32. Belletire J.L., and Mahmoodi N.O. J. Nat. Prod. 55 (1992) 194
33. Horne D.A., Fugmann B., Yakushijin K., and Büchi G. J. Org. Chem. 58 (1993) 62
34. Dener J.M., Zhang L.-H., and Rapoport H. J. Org. Chem. 58 (1993) 1159
35. Shapiro G., and Chengzhi C. Tetrahedron Lett. 33 (1992) 2447
36. Wang Z., and Lu X. Tetrahedron Lett. 38 (1997) 5213
37. Lei A., He M., and Zhang X. J. Am. Chem. Soc. 124 (2002) 8198
38. For additional references related to the synthesis of isopilocarpine 2, see:
39. Preobrashenski N.A., Wompe A.F., and Preobrashenski W.A. Ber. Dtsch. Chem. Ges. 66 (1933) 1187
40. Poljakowa A.M., Preobrashenski W.A., and Preobrashenski N.A. Ber. Dtsch. Chem. Ges. 69 (1936) 1314
41. Zhu G., and Lu X. Tetrahedron: Asymmetry 6 (1995) 1657
42. Braun M., Buhne C., Cougali D., Schaper K., and Frank W. Synthesis (2004) 2905
43. For additional references related to the syntheses of various analogues, see:
44. Gonzalez F.B., Baz J.P., and Espina M.I.R. Tetrahedron Lett. 30 (1989) 2145
45. Sauerberg P., Chen J., WoldeMussie E., and Rapoport H. J. Med. Chem. 32 (1989) 1322
46. Holden K.G., Mattson M.N., Cha K.H., and Rapoport H. J. Org. Chem. 67 (2002) 5913
47. Davies S.G., Roberts P.M., Stephenson P.T., and Thomson J.E. Tetrahedron Lett. 50 (2009) 3509
48. Jones R.G. J. Am. Chem. Soc. 71 (1949) 644
49. Jones R.G., and McLaughlin K.C. J. Am. Chem. Soc. 71 (1949) 2444
50. Bransma L. Preparative Acetylenic Chemistry. 2nd ed. (1988), Elsevier, Amsterdam 231
51. 2) are generally required for unactivated acetylenes. See:
52. Pflieger D., and Muckensturm B. Tetrahedron 45 (1989) 2031
53. Eglinton G., Jones E.R.H., and Whiting M.C. J. Chem. Soc., Chem. Commun. (1952) 2873
54. Newton R.F., Reynolds D.P., Finch M.A.W., Kelly D.R., and Roberts S.M. Tetrahedron Lett. 20 (1979) 3981
55. Treatment of 9 under these conditions resulted in a change of colour of the solution from deep red to yellow, followed by the formation of a light brown precipitate.
56. The formation of (E)-α-ethylidene lactone 5 presumably arises from the isomerisation of the initially formed α-vinyl lactone 8, under the influence of the basic imidazole ring.
57. Since hydrogenation of exclusively (E)-5 gave a 72:28 mixture of pilocarpine 1 and isopilocarpine 2 in quantitative yield, and hydrogenation of an 88:12 mixture of (E)- and (Z)-α-ethylidene lactones 5 (obtained from our first generation racemic synthesis) produced a 70:30 mixture of pilocarpine 1 and isopilocarpine 2 in quantitative yield; this indicates that the double bond geometry within 5 does not have a major impact on the product distributions obtained.
58. An authentic sample of (+)-pilocarpine 1 was kindly supplied by Macfarlan Smith Ltd., Edinburgh; base-catalysed epimerisation of this sample also provided a diastereoisomerically pure sample of (+)-isopilocarpine 2.
59. For reviews, see:
60. Garcia-Urdiales E., Alfonso I., and Gotor V. Chem. Rev. 105 (2005) 313
61. Pesti J.A., and DiCosimo R. Curr. Opin. Drug Discovery Dev. 6 (2003) 884
62. Pesti J.A., and DiCosimo R. Curr. Opin. Drug Discovery Dev. 3 (2000) 764
63. For a comprehensive review of the use of lipases as biocatalysts in organic solvents, see:
64. Wang Y., Chen C., Girdaukas G., and Sih C.J. J. Am. Chem. Soc. 106 (1984) 3695
65. Ader U., Breitgoff D., Klein P., Laumen K.E., and Schneider M.P. Tetrahedron Lett. 30 (1989) 1793
66. Chen C., and Sih C.J. Angew. Chem., Int. Ed. Engl. 28 (1989) 695
67. 1H NMR spectroscopy with chiral shift reagents were unsuccessful, however conversion of 25 to its Mosher's ester derivative enabled ee determination, see Ref. 9 within.
68. van Leusen A.M., Wildeman J., and Oldenziel O.H. J. Org. Chem. 42 (1977) 1153
69. 3, see:. Preobrashenski N.A., Maurit M.E., and Smirnova G.V. Dokl. Akad. Nauk SSSR 81 (1951) 613 see also Ref. 10d within
70. 3, and comparison with an authentic racemic sample.
71. Bailey S., and Harnden M.R. J. Chem. Soc., Perkin Trans. 1 (1988) 2767
72. Wang Y., and Sih C.J. Tetrahedron Lett. 25 (1984) 4999
73. Tsuji K., Terao Y., and Achiwa K. Tetrahedron Lett. 30 (1989) 6189
74. 3N complete racemisation of monoacetate 29 was observed after only 48 h.
75. 1H NMR spectrum of the crude reaction mixture and pure product.
76. 2, CO (1 atm), 20 °C, 17 h.
77. Wenkert E., and Goodwin T.E. Synth. Commun. 7 (1977) 409
78. Colvin E.W., Raphael R.A., and Roberts J.S. J. Chem. Soc., Chem. Commun. (1971) 858
79. Sterzycki R. Synthesis (1979) 724
80. Jacobi P.A., Walker D.G., and Odeh I.M.A. J. Org. Chem. 46 (1981) 2065
81. van Leusen A.M., Hoogenboom B.E., and Siderius H. Tetrahedron Lett. 13 (1972) 2369
82. 2 are added, see Ref. 26 within.
83. 2 at 50 atm pressure in MeOH, giving a 72:28 mixture of 1:2, respectively. Interestingly Pearlman's catalyst showed a small preference for formation of isopilocarpine 2 (56:44 mixture).
84. Jowett H.A.D. J. Chem. Soc., Chem. Commun. (1900) 475
85. Betteridge P.W., Carruthers J.R., Cooper R.I., Prout C.K., and Watkin D.J. Crystals (2001), Chemical Crystallography Laboratory, University of Oxford, UK